Marios Spanakis

847 total citations
54 papers, 616 citations indexed

About

Marios Spanakis is a scholar working on Molecular Biology, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Marios Spanakis has authored 54 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Geriatrics and Gerontology. Recurrent topics in Marios Spanakis's work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Computational Drug Discovery Methods (6 papers). Marios Spanakis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Computational Drug Discovery Methods (6 papers). Marios Spanakis collaborates with scholars based in Greece, United States and Russia. Marios Spanakis's co-authors include Ioannis Niopas, Ioannis S. Vizirianakis, Emmanouil G. Spanakis, Athina Patelarou, Evridiki Patelarou, Vangelis Sakkalis, Dimitrios G. Fatouros, Stelios Sfakianakis, Kostas Marias and Haipeng Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Journal of Pharmaceutical Sciences.

In The Last Decade

Marios Spanakis

49 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marios Spanakis Greece 16 115 88 77 58 54 54 616
Yuntao Jia China 16 118 1.0× 77 0.9× 27 0.4× 56 1.0× 22 0.4× 44 758
KK Mueen Ahmed India 15 178 1.5× 108 1.2× 28 0.4× 36 0.6× 153 2.8× 106 1.1k
Sivasankaran Ponnusankar India 18 210 1.8× 218 2.5× 64 0.8× 42 0.7× 219 4.1× 88 986
Tae‐Eun Kim South Korea 22 220 1.9× 127 1.4× 16 0.2× 121 2.1× 30 0.6× 83 1.6k
Burgunda V. Sweet United States 18 146 1.3× 103 1.2× 110 1.4× 105 1.8× 76 1.4× 50 1.2k
Barbara Schug Germany 16 151 1.3× 112 1.3× 13 0.2× 146 2.5× 53 1.0× 47 991
Bahareh Mohammadi Iran 17 139 1.2× 60 0.7× 20 0.3× 64 1.1× 17 0.3× 55 888
Shashank Kraleti United States 8 348 3.0× 98 1.1× 21 0.3× 45 0.8× 66 1.2× 28 1.3k
Thau‐Ming Cham Taiwan 16 290 2.5× 133 1.5× 40 0.5× 42 0.7× 91 1.7× 47 1.2k
Abdulrahman M. Alahdal Saudi Arabia 16 170 1.5× 45 0.5× 23 0.3× 26 0.4× 21 0.4× 30 621

Countries citing papers authored by Marios Spanakis

Since Specialization
Citations

This map shows the geographic impact of Marios Spanakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios Spanakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios Spanakis more than expected).

Fields of papers citing papers by Marios Spanakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marios Spanakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios Spanakis. The network helps show where Marios Spanakis may publish in the future.

Co-authorship network of co-authors of Marios Spanakis

This figure shows the co-authorship network connecting the top 25 collaborators of Marios Spanakis. A scholar is included among the top collaborators of Marios Spanakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marios Spanakis. Marios Spanakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spanakis, Marios, et al.. (2025). Pharmacoepidemiological Data on Drug–Herb Interactions: Serotonin Syndrome, Arrhythmias and the Emerging Role of Artificial Intelligence. SHILAP Revista de lepidopterología. 4(4). 22–22. 1 indexed citations
2.
Spanakis, Marios, et al.. (2025). Artificial Intelligence Models and Tools for the Assessment of Drug–Herb Interactions. Pharmaceuticals. 18(3). 282–282. 12 indexed citations
3.
Spanakis, Marios, Persefoni Fragkiadaki, Elisavet Renieri, et al.. (2025). Exploiting interrelated genomic, biochemical, nutritional and pathophysiological data to optimize athletic performance (Review). World Academy of Sciences Journal. 7(4). 1–9. 1 indexed citations
4.
Spanakis, Marios, et al.. (2025). Empowering Community Pharmacists for Next-Generation Therapeutics: Assessing Knowledge Needs and Implementing Educational Solutions. Research in Social and Administrative Pharmacy. 21(11). e4–e4. 1 indexed citations
5.
Spanakis, Marios, et al.. (2025). Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. Frontiers in Pharmacology. 16. 1685710–1685710.
6.
Spanakis, Marios, Persefoni Fragkiadaki, Elisavet Renieri, et al.. (2024). Advancing athletic assessment by integrating conventional methods with cutting-edge biomedical technologies for comprehensive performance, wellness, and longevity insights. Frontiers in Sports and Active Living. 5. 1327792–1327792. 5 indexed citations
7.
Taghizadehghalehjoughi, Ali, Cüneyt Çağlayan, Marios Spanakis, et al.. (2024). Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units. Experimental and Therapeutic Medicine. 27(2). 82–82. 5 indexed citations
8.
Spanakis, Marios, Πέτρος Ιωάννου, Evridiki Patelarou, et al.. (2023). Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece. Advances in respiratory medicine. 91(1). 74–92. 1 indexed citations
9.
Spanakis, Marios, et al.. (2023). Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications. SHILAP Revista de lepidopterología. 11(4). 130–130. 2 indexed citations
10.
Hacımüftüoğlu, Ahmet, Mustafa Özkaraca, Mecit Kantarcı, et al.. (2023). Chlorogenic Acid Attenuates Doxorubicin-Induced Oxidative Stress and Markers of Apoptosis in Cardiomyocytes via Nrf2/HO-1 and Dityrosine Signaling. Journal of Personalized Medicine. 13(4). 649–649. 23 indexed citations
11.
Spanakis, Marios, Stelios Sfakianakis, Vangelis Sakkalis, & Emmanouil G. Spanakis. (2019). PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions. SHILAP Revista de lepidopterología. 6(1). 26–26. 20 indexed citations
12.
Spanakis, Marios, et al.. (2019). PharmActa: Personalized pharmaceutical care eHealth platform for patients and pharmacists. Journal of Biomedical Informatics. 100. 103336–103336. 23 indexed citations
13.
Triviai, Ioanna, Marios Spanakis, T. Scherer, et al.. (2018). ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF. Leukemia. 33(1). 99–109. 15 indexed citations
14.
Vizirianakis, Ioannis S., et al.. (2016). Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review). Oncology Reports. 35(4). 1891–1904. 22 indexed citations
15.
Karavasili, Christina, Marios Spanakis, Dionysia Papagiannopoulou, et al.. (2015). Bioactive Self-Assembling Lipid-Like Peptides as Permeation Enhancers for Oral Drug Delivery. Journal of Pharmaceutical Sciences. 104(7). 2304–2311. 19 indexed citations
16.
Spanakis, Marios, et al.. (2013). Pharmacokinetic Interaction between Losartan andRhodiola roseain Rabbits. Pharmacology. 91(1-2). 112–116. 20 indexed citations
17.
Spanakis, Marios & Ioannis Niopas. (2012). Determination of Atenolol in Human Plasma by HPLC with Fluorescence Detection: Validation and Application in a Pharmacokinetic Study. Journal of Chromatographic Science. 51(2). 128–132. 21 indexed citations
18.
Spanakis, Marios, et al.. (2010). Potential drug–drug interactions in prescriptions dispensed in community pharmacies in Greece. Pharmacy World & Science. 32(2). 187–193. 41 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuntao Jia Breakdown of academic impact, for papers by KK Mueen Ahmed Breakdown of academic impact, for papers by Sivasankaran Ponnusankar Breakdown of academic impact, for papers by Tae‐Eun Kim Breakdown of academic impact, for papers by Burgunda V. Sweet Breakdown of academic impact, for papers by Barbara Schug Breakdown of academic impact, for papers by Bahareh Mohammadi Breakdown of academic impact, for papers by Shashank Kraleti Breakdown of academic impact, for papers by Thau‐Ming Cham Breakdown of academic impact, for papers by Abdulrahman M. Alahdal
Rankless by CCL
2026